{"id":49280,"date":"2025-04-01T08:20:44","date_gmt":"2025-04-01T08:20:44","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=45640"},"modified":"2025-04-01T08:20:44","modified_gmt":"2025-04-01T08:20:44","slug":"tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/","title":{"rendered":"TOS 2025: Defesa avan\u00e7ada de CXL e DS"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"49280\" class=\"elementor elementor-49280\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-49c316ce e-flex e-con-boxed e-con e-parent\" data-id=\"49c316ce\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6269f058 elementor-widget elementor-widget-text-editor\" data-id=\"6269f058\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>No final de mar\u00e7o de 2025, o Prof. Farhad Hafezi e o Diretor Executivo da ELZA, Nikki Hafezi, viajaram para Taiwan para participar na <a href=\"https:\/\/www.oph.org.tw\/\">Sociedade Oftalmol\u00f3gica de Taiwan (TOS) <\/a>Reuni\u00e3o da Sociedade Nacional (TOS 2025) e para liderar o Curso CXL 2025 de Taiwan. Esta viagem centrou-se na apresenta\u00e7\u00e3o dos mais recentes avan\u00e7os nas t\u00e9cnicas de reticula\u00e7\u00e3o da c\u00f3rnea (CXL) e na defesa de melhores cuidados para o ceratocone entre as popula\u00e7\u00f5es vulner\u00e1veis.<\/p><p>Durante esta visita ao TOS 2025, os principais objectivos do Prof. Hafezi eram apresentar <a href=\"https:\/\/www.elza-institute.com\/pt\/tag\/eco-cairs\/\">ECO-CAIRS<\/a> e <a href=\"https:\/\/www.elza-institute.com\/pt\/tag\/PACE\/\">ELZA-PACE<\/a>A Comiss\u00e3o Europeia apresentou dois protocolos inovadores de tratamento do ceratocone e, com Nikki Hafezi, destacou o trabalho da Light for Sight Foundation para melhorar os cuidados prestados \u00e0s crian\u00e7as com S\u00edndrome de Down.<\/p><h4><strong>Apresenta\u00e7\u00e3o na TOS 2025<\/strong><\/h4><p>No TOS 2025, o Prof. Hafezi fez apresenta\u00e7\u00f5es sobre o ECO-CAIRS (Extracorporeal Corneal Allogenic Intrastromal Ring Segments) e o ELZA-PACE (CXL personalizado de segunda gera\u00e7\u00e3o). Estas inova\u00e7\u00f5es representam avan\u00e7os substanciais no dom\u00ednio do tratamento do ceratocone.<\/p><ul data-spread=\"false\"><li><strong>ECO-CAIRS<\/strong> envolve o pr\u00e9-tratamento de segmentos de anel corneano alog\u00e9nico com CXL de ultra-alta flu\u00eancia antes da implanta\u00e7\u00e3o. Isto aumenta a rigidez do segmento, melhora o manuseamento cir\u00fargico, erradica os querat\u00f3citos do dador e cria um suporte biocompat\u00edvel que se integra eficazmente na c\u00f3rnea hospedeira e pode induzir um achatamento significativo do cone.<\/li><li><strong>ELZA-PACE<\/strong> utiliza CXL personalizado com o excimer laser que realiza a remo\u00e7\u00e3o do epit\u00e9lio guiada por topografia, permitindo o tratamento seletivo das \u00e1reas mais \u00edngremes da c\u00f3rnea, preservando todo o tecido estromal. Ao aumentar a profundidade e a efic\u00e1cia da reticula\u00e7\u00e3o, oferece melhores resultados visuais.<\/li><\/ul><h4>Colabora\u00e7\u00e3o com a Funda\u00e7\u00e3o Light for Sight<\/h4><p>Paralelamente \u00e0 reuni\u00e3o TOS 2025, o Prof. e a Nikki Hafezi envolveram-se em esfor\u00e7os de colabora\u00e7\u00e3o com a Light for Sight Foundation e outros parceiros, incluindo a Children Are Us Foundation, a Global Vision, a Oculus, a Schwind, a EMAGine e a CSO Italia Distributors. O foco foi a dete\u00e7\u00e3o, o diagn\u00f3stico, o tratamento e a gest\u00e3o do ceratocone em crian\u00e7as com S\u00edndrome de Down.<\/p><p>O programa de v\u00e1rios dias incluiu rastreios utilizando a Oculus Pentacam e demonstra\u00e7\u00f5es ao vivo de CXL epi-on para crian\u00e7as com c\u00f3rneas irregulares. Os esfor\u00e7os educativos foram tamb\u00e9m direcionados para a forma\u00e7\u00e3o de profissionais sobre a forma de realizar rastreios em doentes com baixa ades\u00e3o, com o objetivo de melhorar a dete\u00e7\u00e3o e a interven\u00e7\u00e3o precoces.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-58d8067 e-flex e-con-boxed e-con e-parent\" data-id=\"58d8067\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-a0ef94b e-con-full e-flex e-con e-child\" data-id=\"a0ef94b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a0f7007 elementor-widget elementor-widget-image\" data-id=\"a0f7007\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-team-cxl.jpg\" title=\"\" alt=\"\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-bb17bc8 e-con-full e-flex e-con e-child\" data-id=\"bb17bc8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-988120f elementor-widget elementor-widget-text-editor\" data-id=\"988120f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Conclus\u00e3o<\/strong><\/p><p>A viagem do Prof. e da Nikki Hafezi a Taiwan real\u00e7ou o seu duplo empenhamento na inova\u00e7\u00e3o cient\u00edfica e nos cuidados compassivos. Ao apresentar t\u00e9cnicas inovadoras como a ECO-CAIRS e a ELZA-PACE e ao colaborar em ac\u00e7\u00f5es de sensibiliza\u00e7\u00e3o para doentes vulner\u00e1veis, continua a alargar os limites da reticula\u00e7\u00e3o da c\u00f3rnea, promovendo simultaneamente um acesso equitativo aos cuidados.<\/p><p>Mantenha-se atualizado sobre o trabalho e as inova\u00e7\u00f5es do Prof. e da Nikki Hafezi com\u00a0<a href=\"https:\/\/www.elza-institute.com\/pt\/get-the-newsletter\/\">Boletim informativo do ELZA<\/a>\u00a0e no site do Prof. Hafezi\u00a0<a href=\"https:\/\/www.instagram.com\/prof.farhad.hafezi\/\">Instagram<\/a>\u00a0e Nikki Hafezi's <a href=\"https:\/\/www.instagram.com\/eyelovenikki\/\">Perfis do Instagram<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Durante esta visita ao TOS 2025, o Prof. Hafezi apresentou o ECO-CAIRS e o ELZA-PACE e destacou o trabalho da Light for Sight Foundation para melhorar os cuidados prestados \u00e0s crian\u00e7as com S\u00edndrome de Down.<\/p>","protected":false},"author":4,"featured_media":49222,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[214,1,223,96],"tags":[934,1156,1157,1158,1149,1159,100,993,1160,1161,1162,1163,945,1164,1165,1166,1167,1168,1169,624],"class_list":["post-49280","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farhad-hafezi","category-general-news","category-nikki-hafezi","category-popular-press","tag-best-keratoconus-specialists-switzerland","tag-corneal-cross-linking-zurich","tag-corneal-rehabilitation-zurich","tag-corneal-ring-segment-implantation","tag-customized-cross-linking","tag-cutting-edge-keratoconus-therapies","tag-cxl","tag-eco-cairs","tag-eco-cairs-keratoconus","tag-elza-institute-cxl","tag-elza-institute-keratoconus","tag-elza-institute-zurich","tag-elza-pace","tag-elza-pace-keratoconus","tag-emagine-cxl","tag-farhad-hafezi-keratoconus","tag-innovative-keratoconus-treatments","tag-keratoconus-treatment-innovations","tag-keratoconus-treatment-zurich","tag-pace"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TOS 2025: Advanced CXL and DS advocacy - The ELZA Institute<\/title>\n<meta name=\"description\" content=\"Prof. Hafezi presents ELZA&#039;s ECO-CAIRS, ELZA-PACE, and advanced CXL techniques at the Taiwanese Ophthalmological Society (TOS 2025) meeting.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TOS 2025: Advanced CXL and DS advocacy - The ELZA Institute\" \/>\n<meta property=\"og:description\" content=\"Prof. Hafezi presents ELZA&#039;s ECO-CAIRS, ELZA-PACE, and advanced CXL techniques at the Taiwanese Ophthalmological Society (TOS 2025) meeting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-01T08:20:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"TOS 2025: Advanced CXL and DS advocacy\",\"datePublished\":\"2025-04-01T08:20:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/\"},\"wordCount\":388,\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg\",\"keywords\":[\"best keratoconus specialists Switzerland\",\"corneal cross-linking Zurich\",\"corneal rehabilitation Zurich\",\"corneal ring segment implantation\",\"customized cross-linking\",\"cutting-edge keratoconus therapies\",\"CXL\",\"eco-cairs\",\"ECO-CAIRS keratoconus\",\"ELZA Institute CXL\",\"ELZA Institute keratoconus\",\"ELZA Institute Zurich\",\"elza-pace\",\"ELZA-PACE keratoconus\",\"EMAGine CXL\",\"Farhad Hafezi keratoconus\",\"innovative keratoconus treatments\",\"keratoconus treatment innovations\",\"keratoconus treatment Zurich\",\"pace\"],\"articleSection\":[\"Farhad Hafezi\",\"News\",\"Nikki Hafezi\",\"Popular press\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/\",\"url\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/\",\"name\":\"TOS 2025: Advanced CXL and DS advocacy - The ELZA Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg\",\"datePublished\":\"2025-04-01T08:20:44+00:00\",\"description\":\"Prof. Hafezi presents ELZA's ECO-CAIRS, ELZA-PACE, and advanced CXL techniques at the Taiwanese Ophthalmological Society (TOS 2025) meeting.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg\",\"width\":1200,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elza-institute.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.elza-institute.com\/general-news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"TOS 2025: Advanced CXL and DS advocacy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elza-institute.com\/#website\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elza-institute.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elza-institute.com\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ELZA.Institute\/\",\"https:\/\/x.com\/ELZA_Institute\",\"https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TOS 2025: Defesa avan\u00e7ada de CXL e DS - Instituto ELZA","description":"O Prof. Hafezi apresenta as t\u00e9cnicas ECO-CAIRS, ELZA-PACE e CXL avan\u00e7adas da ELZA na reuni\u00e3o da Sociedade Oftalmol\u00f3gica de Taiwan (TOS 2025).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/","og_locale":"pt_PT","og_type":"article","og_title":"TOS 2025: Advanced CXL and DS advocacy - The ELZA Institute","og_description":"Prof. Hafezi presents ELZA's ECO-CAIRS, ELZA-PACE, and advanced CXL techniques at the Taiwanese Ophthalmological Society (TOS 2025) meeting.","og_url":"https:\/\/www.elza-institute.com\/pt\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2025-04-01T08:20:44+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"TOS 2025: Advanced CXL and DS advocacy","datePublished":"2025-04-01T08:20:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/"},"wordCount":388,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg","keywords":["best keratoconus specialists Switzerland","corneal cross-linking Zurich","corneal rehabilitation Zurich","corneal ring segment implantation","customized cross-linking","cutting-edge keratoconus therapies","CXL","eco-cairs","ECO-CAIRS keratoconus","ELZA Institute CXL","ELZA Institute keratoconus","ELZA Institute Zurich","elza-pace","ELZA-PACE keratoconus","EMAGine CXL","Farhad Hafezi keratoconus","innovative keratoconus treatments","keratoconus treatment innovations","keratoconus treatment Zurich","pace"],"articleSection":["Farhad Hafezi","News","Nikki Hafezi","Popular press"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/","url":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/","name":"TOS 2025: Defesa avan\u00e7ada de CXL e DS - Instituto ELZA","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg","datePublished":"2025-04-01T08:20:44+00:00","description":"O Prof. Hafezi apresenta as t\u00e9cnicas ECO-CAIRS, ELZA-PACE e CXL avan\u00e7adas da ELZA na reuni\u00e3o da Sociedade Oftalmol\u00f3gica de Taiwan (TOS 2025).","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2025\/04\/tos-2025-featured-image.jpg","width":1200,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/tos-2025-corneal-cross-linking-and-advocacy-for-down-syndrome-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.elza-institute.com\/general-news\/"},{"@type":"ListItem","position":3,"name":"TOS 2025: Advanced CXL and DS advocacy"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/49280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=49280"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/49280\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/49222"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=49280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=49280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=49280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}